Addressing steroid phobia: Improving the risk-benefit ratio with new agents
Skoner JD et al. - Although some of the studies were flawed, featured drugs that are less commonly prescribed today, or both, adverse effects from chronic ICSs use are still a cause of concern today. Current therapies are designed to be efficacious at minimal doses, limiting potential side effects, increasing adherence, and improving asthma control. [more...]
|
|
|
